Dr. William Rader Stem Cell Of America - Breakthrough Parkinson's Treatment Stem Cell Of America http://www.drwilliamrader.com - Breakthrough Stem Cell Treatment for Parkinson'sFrom:William RaderViews:7 0ratingsTime:02:19More inScience Technology Read the original post: Dr. William Rader … Continue reading →

Wigan v Bradford. Click here to bet. The Bantams, fifth in npower League Two, are the lowest-ranked side left in the competition and face the tough task of beating Barclays Premier League opposition on their own ground. But Parkinson wants his players to enjoy the experience and concentrate on doing themselves justice at the DW Stadium. "It's our reward for a good first third to the season," he told the club's Bantams Player. "It is great day out for the football club. "We'll take 5,000 fans with us and it's a night we'll really enjoy if we put in a good performance. "To get a result we'll have to play above and beyond what we normally do and Wigan will have to play below their normal standard, but cup shocks do happen. The only pressure on us is to perform and that's what we'll do. "We go without a few key players but it's an opportunity for a few of the players who haven't played for a while to get a chance, and an opportunity to give a few youngsters a chance. And what an occasion it will be for the young lads who will at least be on the … Continue reading →

A study at the University of Virginia could lead to a cure for tremor caused by Parkinson's disease. It could even be the first step toward treating the symptoms of other movement disorders. It's a groundbreaking study and if it works, one ultrasound to the brain could be an alternative to brain surgery for Parkinson's patients. "Patients and their families and their doctors are all very interested in minimally invasive treatments," said UVA neurosurgeon Dr. Jeff Elias. That's just what Dr. Elias and his colleagues at UVA are working towards - a minimally invasive treatment for Parkinson's tremor. Dr. Elias said, "We're utilizing focused ultrasound technology and this is technology that's coupled with MRI guidance, so we have the best of MRI visualization and the noninvasiveness of ultrasound, so that there's no incisions or holes drilled." The study is funded in part by the Focused Ultrasound Foundation. "The reason for funding a Parkinson's study, first of all, there's a large unmet clinical need," said Matt Eames with the Focused Ultrasound Foundation. "A lot of patients are not interested in deep brain stimulation." If the study is successful, the treatment could be an alternative to brain surgery. "This technology utilizes over … Continue reading →

The Mirken Department of Neurology at Beth Israel Medical Center received a plaque from the National Parkinson Foundation (NPF) to celebrate the departments continued designation as an NPF Center of Excellence since 1996. Peter Schmidt, PhD, Chief Information Officer and Vice President of Programs at the foundation presented the plaque to Susan Bressman M.D., Chair of the Mirken Department of Neurology, who accepted the honor on behalf of her exemplary team of neurology specialists. New York, NY (PRWEB) October 30, 2012 The National Parkinson Foundation is pleased to continue our association with the great Parkinsons Center at Beth Israel Medical Center, said Peter Schmidt, PhD, Chief Information Officer and Vice President of Programs at the foundation, who presented the plaque. The challenges that face us in advancing the state of Parkinsons care are tremendous and our community is lucky to have Dr. Bressman and her team on our side as we endeavor to surmount them. Susan Bressman, M.D., Chair of the Mirken Department of Neurology, accepted the plaque on behalf of her exemplary team. National Parkinson Foundation Centers of Excellence are widely renowned for outstanding performance in Parkinsons research, care and outreach. Recognized by their medical peers as leaders in … Continue reading →

Bradford boss Phil Parkinson is relaxed ahead of his side's Capital One Cup tie with Wigan on Tuesday night. Phil Parkinson: In relaxed mood The Bantams, fifth in League Two, are the lowest-ranked side left in the competition and face the tough task of beating Premier League opposition on their own ground. But Parkinson wants his players to enjoy the experience and concentrate on doing themselves justice at the DW Stadium. "It's our reward for a good first third to the season," he told the club's Bantams Player. "It is great day out for the football club. "We'll take 5,000 fans with us and it's a night we'll really enjoy if we put in a good performance. "To get a result we'll have to play above and beyond what we normally do and Wigan will have to play below their normal standard, but cup shocks do happen. The only pressure on us is to perform and that's what we'll do. "We go without a few key players but it's an opportunity for a few of the players who haven't played for a while to get a chance, and an opportunity to give a few youngsters a chance. And what an … Continue reading →

SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptosis therapeutic protein MANF, today announced that it intends to pursue the identification of one or multiple therapeutic indications for its lead therapeutic candidate MANF that could lead to the therapy receiving orphan drug designation(s) with the Food and Drug Administration (FDA). The strategy is centred on exploiting MANF's unique mechanism of action related to facilitating proper protein folding and processing in the endoplasmic reticulum in order to identify rare and/or ultra-rare diseases where MANF treatment may play a significant role in improving patient outcomes in disease states where no other treatment options are currently available. "Protein misfolding and aggregation plays a significant role in a wide range of human diseases, including very common diseases such as Parkinson's and Alzheimer's, as well as many rare and ultra-rare diseases," said Gerald E. Commissiong, President & CEO of Amarantus. "MANF has a unique ability to mediate protein folding in an extracellular fashion, making it potentially an ideal biologic drug candidate for a wide range of human conditions. Parkinson's continues to remain the … Continue reading →